Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Ball

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Proteome Research|October 9, 2012
An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasisJudith Nicholson, Kalainanghi Neelagandan, Anne-Sophie Huart, et al.
Journal of Molecular Biology|July 10, 2007
Bile acid interactions with rabbit ileal lipid binding protein and an engineered helixless variant reveal novel ligand binding properties of a versatile beta-clam shell protein scaffoldNikolaos Kouvatsos, Victoria Thurston, Kathryn Ball, et al.
The FEBS Journal|August 30, 2008
ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1Craig Stevens, Susanne Pettersson, Bartosz Wawrzynow, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 30, 2025
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2022
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White PaperKathryn Ball, Gerard Bruin, Enrique Escandón, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 25, 2025
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Neurology and Therapy|January 10, 2026
Summary of Research: Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Antiviral Research|June 28, 2024
Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2Alison Daniels, Monikaben Padariya, Sarah Fletcher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2019
Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation StrategyPhilippe B Pierrillas, Emilie Henin, Kathryn Ball, et al.
Proteomics|June 19, 2013
Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometryLenka Hernychova, Petr Man, Chandra Verma, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Proteome Research|October 9, 2012
An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasisJudith Nicholson, Kalainanghi Neelagandan, Anne-Sophie Huart, et al.
Journal of Molecular Biology|July 10, 2007
Bile acid interactions with rabbit ileal lipid binding protein and an engineered helixless variant reveal novel ligand binding properties of a versatile beta-clam shell protein scaffoldNikolaos Kouvatsos, Victoria Thurston, Kathryn Ball, et al.
The FEBS Journal|August 30, 2008
ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1Craig Stevens, Susanne Pettersson, Bartosz Wawrzynow, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 30, 2025
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2022
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White PaperKathryn Ball, Gerard Bruin, Enrique Escandón, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 25, 2025
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Neurology and Therapy|January 10, 2026
Summary of Research: Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the Global MAPLE-MS Pharmacovigilance ProgramKerstin Hellwig, Hugh H Tilson, Sandra Thiel, et al.
Antiviral Research|June 28, 2024
Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2Alison Daniels, Monikaben Padariya, Sarah Fletcher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2019
Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation StrategyPhilippe B Pierrillas, Emilie Henin, Kathryn Ball, et al.
Proteomics|June 19, 2013
Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometryLenka Hernychova, Petr Man, Chandra Verma, et al.
Pageof 4